Identification of the lysyl oxidase gene as a target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2417-2421

  Tan, Rosemary Sok Pin ^c   Taniguchi, Tadatsugu ^a   Harada, Hisashi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERFERON; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL STRAIN 3T3; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC SYSTEM TUMOR; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; MICE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEIN P21(RAS); PHENOTYPE; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN-LYSINE 6-OXIDASE; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 0029882276     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Weissmann, C , and Weber, H. The interferon genes. Prog. Nucleic Acids Res Mol Biol , 33: 251-300, 1986
2. De Maeyer, E , and De Maeyer-Guignard, J Interferons and Other Regulatory Cytokines New York John Wiley and Sons, 1988
3. Vilcek, J Interferons. In: M A. Sporn and B. Roberts (eds.), Peptide Growth Factors and Their Receptors II. pp 3-38. Berlin, Springer-Verlag, 1990.
4. Tanaka, N., and Taniguchi, T. Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the IFN system Adv. Immunol , 52. 263-281, 1992
5. Miyamoto, M., Fujita, T., Kimura, Y , Maruyama, M., Harada, H , Sudo, H., Miyata, T , and Taniguchi, T Regulated expression of a gene encoding a nuclear factor. IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell, 54: 903-913, 1988
6. Harada, H., Fujita, T., Miyamoto, M , Kimura, Y., Maruyama, M., Furia, A., Miyata, T., and Taniguchi, T Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell, 58. 729-739, 1989
7. Lamphier, M., and Taniguchi, T The transcription factors IRF-1 and IRF-2: linking the Interferon response and cell growth control Immunologist, 2: 167-171, 1994.
8. Tanaka, N., Kawakami, T., and Taniguchi, T Recognition sequences of IRF-1 and IRF-2: regulators of cell growth and the interferon system. Mol. Cell Biol , 13 4531-4538, 1993
9. Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E. L , and Taniguchi, T. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1 Nature (Lond ), 337: 270-272, 1989
10. Harada, H., Willison, K , Sakakibara, J , Miyamoto, M , Fujita, T., and Taniguchi, T Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell, 63: 303-312, 1990.
11. Harada, H., Kitagawa, M , Tanaka, N , Yamamoto, H , Harada, K., Ishihara, M., and Taniguchi, T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors 1 and 2 Science (Washington DC), 259: 971-974, 1993.
12. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T W., and Taniguchi, T Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77: 829-839, 1994.
13. Tanaka, N., Ishihara, M., and Taniguchi, T. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett , 83: 191-196, 1994.
14. Willman, C. L , Sever, C. E., Pallavicini, M. G., Harada, H , Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., and Taniguchi, T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science (Washington DC), 259. 968-971, 1993.
15. Harada, H., Kondo, T., Ogawa, S., Tamura, T , Kitagawa, M., Tanaka, N., Lamphier, M., Hirai, H., and Taniguchi, T. Accelerated exon skipping of the IRF-1 mRNA in human myelodysplasia/leakemia: a possible mechanism of tumor suppressor inactivation. Oncogene, 9: 3313-3320, 1994.
16. Kimura, T., Nakayama, K., Penninger, J , Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N , Kamijo, R , Vilcek, J , Mak, T W., and Taniguchi, T Involvement of the IRF-1 transcription factor in anti viral responses to interferons. Science (Washington DC), 264: 1921-1924, 1994
17. Kimura, T , Kadokawa, Y., Harada, H , Matsumoto, M., Sato, M., Kashiwazaki, Y., Tarutani, M., Tan, R. S-P., Takasugi, T., Matsuyama, T., Mak, T. W., Noguchi, S., and Taniguchi, T. Essential and non-redundant roles of p48(ISGF3γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells, I 115-124, 1996
18. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257. 967-971, 1992
19. Pinnell, S. R., and Martin, G. R Enzymatic conversion of lysine in peptide linkage to α-amminoadipic-δ-semialdehyde by an extract from bone. Proc. Natl. Acad. Sci. USA, 61 708-716, 1968.
20. Kagan, H. M. Characterization and regulation of lysyl oxidase. In. R. P. Mecham (ed.), Regulation of Matrix Accumulation, Vol. 1, pp. 321-398. New York: Academic Press, 1986
21. Kagan, H. M., and Trackman, P. C. Properties and function of lysyl oxidase. Am. J. Respir. Cell Mol. Biol , 5: 296-210, 1991.
22. Contente, S., Kenyon, K., Rimoldi, D , and Friedman, R. M Expression of gene rrg is associated with reversion of NIH3T3 transformed by LTR-c-H-ras Science (Washington DC), 249: 796-798, 1990
23. Hajnal, A., Klemenz, R., and Schafer, R. Up-regulation of lysyl oxidase in spontaneous revenants of H-ras-transformed rat fibroblasts. Cancer Res , 53: 4670-4675, 1993.
24. Matsuyama, T., Kimura, T., Kitagawa, M , Pfeffer, K., Kawakami, T., Watanabe, N., Kundig, T M., Amakawa, R., Kishihara, K., Wakeham, A., Potter, J., Furlonger, C. L., Narendran, A., Suzuki, H , Ohashi, P. S , Paige, C. J., Taniguchi, T., and Mak, T W. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell, 75: 83-97, 1993.
25. Liang, P , Averboukh, L., and Pardee, A. B. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res , 21: 3269-3275, 1993.
26. lck, a protein tyrosine kinase which mediates interleukin-2-induced activation of the c-fos gene. Mol. Cell Biol., 14: 5812-5819, 1994.
27. Kato, K , Kanamori, A., and Kondoh, H Rapid and transient decrease of N-myc expression in retinoic acid-induced differentiation of OTF9 teratocarcinoma stem cells. Mol. Cell. Biol , 10: 486-491, 1990.
28. Contente, S., Csiszar, K., Kenyon, K., and Friedman, R M. Structure of the mouse lysyl oxidase gene. Genomics, 16: 395-400, 1993
29. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S I., Kimura, T , Green, S. J., Mak, T W , Taniguchi, T , and Vilcek, J. Requirement for transcription factor, IRF-1 in NO synthase induction in macrophages Science (Washington DC), 263: 1612-1615, 1994.
30. Kenyon, K., Contente, S., Trackman, P. C., Tang, J , Kagan, H. M , and Friedman, R. M. Lysyl oxidase and rrg messenger RNA. Science (Washington DC), 253. 802, 1991.
31. Kuivaniemi, H., Peltonen, L., and Kivirikko, K. I. Type IX Ehlers-Danlos syndrome and Menkes syndrome. The decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein. Am. J. Hum. Genet., 37: 798-808, 1985.
32. Royce, P. M., and Steinmann, B Markedly reduced activity of lysyl oxidase in skin and aorta from a patient with Menkes' disease showing unusually severe connective tissue manifestation. Pediatr. Res., 28. 136-141, 1990.